fda glp-1 compounding enforcement september 2025 Cracks Down on Compounded Drugs | Paul Healy 💊🧬 posted on the topic FDA issued 25 warning letters

International journal of molecular sciences , 24 (15), 12152

Results GLP-1RA reduced major cardiovascular events (MACE) by 14% (HR = 0.86, 95% CI 0.790.94, P = 0.006) with a non-significant heterogeneity between subgroups of patients with and without cardiovascular disease (P = 0.127)

This gives your cells enough time to turn over and your tissues enough time to saturate with the nutrients they need

Everything of concern was addressed, I felt heard and supportive

Wilson, K., Fry, G

173 Its research findings were recently presented orally at the 83rd Scientific Sessions of the American Diabetes Association and published in the New England Journal of Medicine